David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.63B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SPCX
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.78% |
| 2 | Financials | 8.35% |
| 3 | Healthcare | 7.91% |
| 4 | Consumer Discretionary | 7.83% |
| 5 | Industrials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
CALL
Standex International
SXI
$3.67B
| $2.72M | ﹤0.01% |
7,600
+4,100
| +117% | +$1.15M |
|
2827
CALL
Workday
WDAY
$49.2B
| $2.72M | ﹤0.01% |
22,200
-133,200
| -86% | -$16.9M |
|
|
PPTA
2828
CALL
Perpetua Resources
PPTA
$3.24B
| $2.72M | ﹤0.01% |
130,900
| – | – |
|
|
NFGC
2829
New Found Gold
NFGC
$730M
| $2.71M | ﹤0.01% |
1,758,915
-326,700
| -16% | -$626K |
|
2830
State Street SPDR S&P Global Natural Resources ETF
GNR
$5.2B
| $2.71M | ﹤0.01% |
+40,272
| New | +$2.94M |
|
2831
PUT
Vermilion Energy
VET
$1.92B
| $2.71M | ﹤0.01% |
290,000
+50,000
| +21% | +$594K |
|
2832
Haemonetics
HAE
$4.93B
| $2.7M | ﹤0.01% |
36,040
-154,610
| -81% | -$9.93M |
|
2833
TTM Technologies
TTMI
$11.3B
| $2.7M | ﹤0.01% |
14,446
+1,111
| +8% | +$179K |
|
|
2834
Workday
WDAY
$49.2B
| $2.7M | ﹤0.01% |
22,069
-10,073
| -31% | -$1.28M |
|
2835
Castle Biosciences
CSTL
$1.02B
| $2.69M | ﹤0.01% |
112,789
-99,177
| -47% | -$2.21M |
|
2836
Rubrik
RBRK
$20.2B
| $2.69M | ﹤0.01% |
33,464
-277
| -0.8% | -$17.4K |
|
2837
Zai Lab
ZLAB
$2.88B
| $2.68M | ﹤0.01% |
141,158
+77,915
| +123% | +$1.54M |
|
2838
CALL
Fiverr
FVRR
$337M
| $2.67M | ﹤0.01% |
259,100
| – | – |
|
2839
CALL
Ball Corp
BALL
$17.1B
| $2.67M | ﹤0.01% |
+42,800
| New | +$2.52M |
|
2840
GeneDx Holdings
WGS
$2.54B
| $2.67M | ﹤0.01% |
38,877
+19,974
| +106% | +$1.14M |
|
|
PPLI
2841
People Inc
PPLI
$2.89B
| $2.67M | ﹤0.01% |
57,762
-3,366
| -6% | -$144K |
|
2842
Old Second Bancorp
OSBC
$1.29B
| $2.67M | ﹤0.01% |
+114,326
| New | +$2.44M |
|
2843
Universal Insurance Holdings
UVE
$1.21B
| $2.66M | ﹤0.01% |
64,380
+6,850
| +12% | +$258K |
|
2844
CALL
BellRing Brands
BRBR
$1.26B
| $2.66M | ﹤0.01% |
205,300
-19,700
| -9% | -$238K |
|
2845
Zumiez
ZUMZ
$312M
| $2.65M | ﹤0.01% |
149,052
+52,997
| +55% | +$1.18M |
|
2846
Zentalis Pharmaceuticals
ZNTL
$356M
| $2.65M | ﹤0.01% |
546,566
-937,532
| -63% | -$3.74M |
|
2847
CALL
Eldorado Gold
EGO
$12.1B
| $2.65M | ﹤0.01% |
85,200
| – | – |
|
2848
Metallus
MTUS
$776M
| $2.64M | ﹤0.01% |
141,258
+72,260
| +105% | +$1.36M |
|
2849
Arcturus Therapeutics
ARCT
$408M
| $2.64M | ﹤0.01% |
392,358
+140,324
| +56% | +$1.11M |
|
|
QADR
2850
QDRO Acquisition Corp
QADR
| $2.64M | ﹤0.01% |
+266,001
| New | +$2.64M |
|
Similar funds
David Shaw's Q2 2026 Portfolio in Review
As of Q2 2026, David Shaw held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
David Shaw deployed $7.01B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- David Shaw's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.63B increase.
- David Shaw's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- David Shaw fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- David Shaw's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- David Shaw opened 872 new positions and closed 527 in Q2 2026.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.